See Clearly Again
From corneal cross-linking to advanced contact lens fittings, we offer a range of cutting-edge treatments to help you see clearly again. Our team will guide you through every step of your treatment journey, ensuring you feel comfortable and informed throughout the process.
What Is Keratoconus?
Keratoconus, often referred to as “KC,” is a non-inflammatory eye condition in which the typically round dome-shaped cornea progressively thins and weakens, causing the development of a cone-like bulge and optical irregularity of the cornea. This causes “static” in your vision. Here’s what you should know:
- Can result in significant vision loss
- May lead to corneal transplant in severe cases
- Affects both males and females
- Affects all ethnicities
- 10% of people with KC have affected relatives
- People with Down syndrome are 20 times more likely to be affected
Symptoms of Keratoconus
Keratoconus typically first appears in individuals who are in their late teens or early twenties, and may progress for 10-20 years and then slow or stabilize. Each eye may be affected differently. In the early stages of keratoconus, people might experience:
- Slight blurring of vision
- Distortion of vision
- Increased sensitivity to light
The cornea is responsible for focusing most of the light that comes into the eye. Therefore, abnormalities of the cornea, such as keratoconus, can have a major impact on how an individual sees the world, making simple tasks such as driving a car or reading a book very difficult.
What Is iLink™ Corneal
Cross-Linking?
iLink™ corneal cross-linking is a minimally invasive outpatient procedure that combines the use of ultraviolet light and specially formulated eye drops to stiffen and strengthen corneas that have been weakened by disease or refractive surgery. Cross-linking is considered the standard of care around the world for progressive keratoconus and corneal ectasia following refractive surgery.
Is Cross-Linking Right For Me?
Patients who have been diagnosed with progressive Keratoconus or Corneal Ectasia following refractive surgery should ask their doctor about iLink™ corneal cross-linking. Our practice is proud to offer patients the first and only FDA-approved therapeutic solution for the treatment of progressive Keratoconus. Now, patients who once had little to no therapeutic option to treat Keratoconus have the opportunity to slow or halt the progression of this sight-threatening disease. For more information about the iLink™ procedure for the treatment of Keratoconus and Corneal Ectasia following refractive surgery, visit livingwithkeratoconus.com.
